About Menactra Injection 4mcg / 0.5 ml
Menactra Injection contains meningococcal conjugate vaccine, used to prevent meningococcal disease.
Menactra Injection 4mcg / 0.5 ml Uses
- Prevents invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135
- Recommended for travellers going for Hajj or Umrah, as Saudi Arabia mandates it for pilgrim visas
- Given to people with certain immune conditions such as asplenia or complement deficiencies who face higher infection risk
- Used for military recruits, students living in dormitories, and laboratory workers exposed to the bacteria
- Included in routine adolescent immunization schedules in many countries to prevent meningitis
Menactra Injection 4mcg / 0.5 ml Benefits
- Provides protection against four major meningococcal serogroups in a single vaccine
- Reduces the risk of life threatening meningitis and bloodstream infection (septicaemia)
- Offers long lasting immunity with a well established safety record in adolescents and adults
- Helps fulfil Saudi Arabia's mandatory vaccination requirement for Hajj and Umrah visas
- Conjugate technology produces a stronger, longer lasting immune response than older polysaccharide vaccines
What Experts Say
Physicians recommend a single 0.5ml intramuscular dose for most adolescents and adults, since one injection generates protective antibody levels against all four covered serogroups. Infants and young children may need a multi dose primary series, with intervals adjusted for age and underlying risk factors.
Doctors monitor patients for fifteen to thirty minutes after injection to watch for rare allergic reactions, since the vaccine contains a diphtheria toxoid carrier protein some individuals may react to. Mild fever, soreness and fatigue are expected and usually resolve within a day or two.
The conjugate design links meningococcal polysaccharide to a protein carrier, training the immune system to mount a faster, stronger response on future exposure than older plain polysaccharide vaccines. This mechanism also supports better antibody memory in younger patients whose immune systems respond poorly to polysaccharide antigens alone.
Drug Class
- Meningococcal Conjugate Vaccine
- Polysaccharide Protein Conjugate Vaccine
- Bacterial Vaccine (Immunizing Biological Agent)
Menactra Injection 4mcg / 0.5 ml Uses in Urdu
- یہ ویکسین میننجائٹس اور خون میں انفیکشن پیدا کرنے والے بیکٹیریا نیسیریا مینن جائٹائیڈس سے تحفظ فراہم کرتی ہے۔
- حج اور عمرہ پر جانے والے افراد کے لیے سعودی عرب کی جانب سے یہ ویکسین لازمی قرار دی گئی ہے۔
- کمزور مدافعتی نظام یا تلی نکالے جانے کے بعد میننجائٹس کے خطرے کو کم کرنے کے لیے استعمال ہوتی ہے۔
- ہاسٹل میں رہنے والے طلبہ اور فوجی بھرتیوں میں بیماری کے پھیلاؤ کو روکنے کے لیے تجویز کی جاتی ہے۔
- یہ انجیکشن صرف ڈاکٹر یا تربیت یافتہ طبی عملہ ہی لگاتا ہے۔
Menactra Injection 4mcg / 0.5 ml formula
- Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Serogroups A, C, Y and W-135)
How to use Menactra Injection 4mcg / 0.5 ml?
- Administered only by a doctor or trained healthcare provider as an intramuscular injection, usually in the upper arm
- Given as a single 0.5ml dose for people aged 9 months to 55 years, per the approved schedule
- Infants aged 9 to 23 months may require two doses given three months apart
- Not for self injection or home use under any circumstances
- Inform your doctor about allergies, pregnancy, or current illness before vaccination
Drug Interactions
- Immunosuppressive Drugs: Medicines like corticosteroids or chemotherapy can reduce the vaccine's effectiveness.
- Other Vaccines: Can generally be given alongside other routine vaccines but at separate injection sites; discuss timing with your doctor.
- Immunoglobulins: Recent immunoglobulin therapy may affect the immune response to this vaccine.
Risks and warnings
- Allergic Reaction: Seek immediate medical care for difficulty breathing, swelling of the face or throat, or hives after the injection.
- Guillain Barre Syndrome: Rare cases of this nerve disorder have been reported after meningococcal vaccination; inform your doctor of any prior history.
- Fever in Children: Young children may develop fever after vaccination; monitor temperature and consult a doctor if it persists.
- Immunocompromised Patients: People with weakened immune systems may have a reduced immune response and should discuss timing with their doctor.
- Pregnancy and Breastfeeding: Use only if clearly needed and after discussing risks and benefits with a doctor.
Menactra Injection 4mcg / 0.5 ml Side Effects
- Pain, redness or swelling at the injection site
- Mild fever
- Headache
- Fatigue and irritability
- Muscle or joint pain
- Nausea
- Decreased appetite in children
- Dizziness
- Rarely, severe allergic reaction (anaphylaxis)
- Rarely, fainting shortly after injection
Storage Conditions
- Store in a refrigerator between 2°C and 8°C at all times
- Do not freeze; discard the vial if it has been frozen
- Keep the vial in its outer carton to protect from light
- Do not use after the expiry date printed on the pack
- Once opened, use immediately and discard any unused portion
- Keep out of reach of children
